Unique ID issued by UMIN | UMIN000006333 |
---|---|
Receipt number | R000007509 |
Scientific Title | Randomized trial on the effect of non-calcium-containing phosphate binder lanthanum carbonate and calcium carbonate on FGF23 in hemodialysis patients |
Date of disclosure of the study information | 2011/09/15 |
Last modified on | 2012/09/13 12:56:59 |
Randomized trial on the effect of non-calcium-containing phosphate binder lanthanum carbonate and calcium carbonate on FGF23 in hemodialysis patients
Randomized trial on the effect of non-calcium-containing phosphate binder lanthanum carbonate and calcium carbonate on FGF23 in hemodialysis patients
Randomized trial on the effect of non-calcium-containing phosphate binder lanthanum carbonate and calcium carbonate on FGF23 in hemodialysis patients
Randomized trial on the effect of non-calcium-containing phosphate binder lanthanum carbonate and calcium carbonate on FGF23 in hemodialysis patients
Japan |
Chronic kidney disease
Nephrology |
Others
NO
To compare the effect of lanthanum carbonate and calcium carbonate on serum phosphate and FGF23 levels in newly initiated hemodialysis patients with hyperphosphatemia
Efficacy
Confirmatory
Pragmatic
Not applicable
Change of serum FGF23 levels
Serum phosphate level achievement rate as defined by the JSDT guideline
Safety
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
NO
No need to know
2
Treatment
Medicine |
Lanthanum carbonate treatment (Follow-up: 3 months)
Calcium carbonate treatment (Follow-up: 3 months)
20 | years-old | <= |
Not applicable |
Male and Female
1) Newly initiated hemodialysis patients for within 2 weeks
2) Age >20 years old
3) Patients with written IC
1) Malignancy of any type at enrollment
2) History of hypersensitivity to any of the ingredients of Lanthanum carbonate or Calcium carbonate
3) Severe hepatic dysfunction
4) Active digestive ulcer, ulcerative colitis, Crohn's disease and constriction of intestine
5) Pregnant or possibly pregnant women
6) Women on lactation
7) Ineligible patients according to the investigator's judgment
40
1st name | |
Middle name | |
Last name | Yasuhiko Tomino |
Juntendo University Faculty of Medicine
Division of Nephrology, Department of Internal Medicine
2-1-1 Hongo Bunkyo-ku, Tokyo, Japan
+81-3-3813-3111
1st name | |
Middle name | |
Last name | Junichiro Nakata |
Juntendo University Faculty of Medicine
Division of Nephrology, Department of Internal Medicine
2-1-1 Hongo Bunkyo-ku, Tokyo, Japan
jnakata@juntendo.ac.jp
Juntendo University
None
Self funding
Japan
NO
順天堂大学医学部附属順天堂医院(東京都)
2011 | Year | 09 | Month | 15 | Day |
Unpublished
Completed
2011 | Year | 08 | Month | 01 | Day |
2011 | Year | 08 | Month | 01 | Day |
2011 | Year | 09 | Month | 12 | Day |
2012 | Year | 09 | Month | 13 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007509
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |